Rezivertinib
Rezivertinib (BPI-7711) is an orally available, selective and potent inhibitor of tyrosine kinase (EGFR) with antitumor activity for central nervous system disorders.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.57
Molecular Formula
C27H30N6O3
Notes
Research use only, not for human use.
Receptor
EGFR
CAS Number
1835667-12-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
